Thus, high expression levels of anti-apoptotic proteins Bcl-2 and Bcl-xL have been reported to correlate with cisplatin resistance and tumor recurrence in different cancers including non-small cell lung cancer (NSCLC), head and neck, ovarian, and breast [64–68]. Here, BCL2L1 is linked to non-small cell lung carcinoma.